Meso
Aftermath
Archived
Biotech resurgence: M&A activity and market performance
Activity declining — narrative losing relevance.
Score
0.3
Velocity
▲ 0.0
Articles
13
Sources
2
Sentiment Timeline
Sector Performance
Stock Performance
Event Timeline
Related Articles
This Biotech Was Quietly Bought Before a $58 Per Share Takeout
Yahoo Finance
·
Mar 21, 2026
This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year
Nasdaq
·
Mar 20, 2026
My Top 3 Drug Stocks for March 2026
Nasdaq
·
Mar 20, 2026
Why biotech is back: IBT portfolio manager’s view
Yahoo Finance
·
Mar 20, 2026